FDA Adverse Event Injury Summary report: N

ARTZ DISPO

MDR report key: 3984612 · Received August 6, 2014

Report

Report Number
9612392-2014-00009
Event Type
Injury
Date Received
August 6, 2014
Date of Event
June 26, 2014
Report Date
July 9, 2014
Manufacturer
SEIKAGAKU CORP.,
Product Code
MOZ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

WE ARE UNDER INVESTIGATION IN DETAILS.

Description of Event or Problem · 1

ON (B)(6) 2014, A (B)(6) FEMALE PATIENT RECEIVED 1ST INJECTION OF ARTS DISPO FOR ROTATOR CUFF INJURY IN THE LEFT SHOULDER JOINT. IMMEDIATELY AFTER THE INJECTION, SHOULDER PAIN DEVELOPED. AT THE NIGHT, SHE FELT A CHILL AND HAD FEVER OF 39 DEGREES C. ON (B)(6) 2014, SHE VISITED THE INJECTION PHYSICIAN AND WAS ADMITTED TO THE HOSPITAL WITH THE PURPOSE OF OBSERVATION. NO FLUID WAS RETAINED. NO PUS-FILLED SPACE WAS FOUND IN HER MEDICAL IMAGE. NSAID WAS PRESCRIBED. ON (B)(6) 2014, HER FEVER SUBSIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
459161 ARTZ DISPO ACID, HYALURONIC, INTRAARTICUALR MOZ SEIKAGAKU CORP., NA

Patients

Seq Age Sex Outcome Treatment
1 51 YR Hospitalization LOXONIN TABLET 60MG| MUCOSTA TABLET 100MG| VOLTAREN TAPE 15MG| THIURAGYL TABLET 50 MG